Humbug, the Council of Pharmacy and Chemistry, and the Origin of “The Blind Test” of Therapeutic Efficacy

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

This paper examines an early attempt to purge the medical field of commercial exploitation and promote rational therapeutics. The historical study of the origin of the double-blind randomized controlled trial as a standard of therapeutic efficacy reveals that concerns which seem entirely modern, are actually deeply entrenched in the history of medical research. Specifically, those whose primary concern was with ending the use of inefficacious, and sometimes positively dangerous drugs, found themselves in an ideological battle with those who benefitted financially from their use.

Original languageEnglish
Title of host publicationBoston Studies in the Philosophy and History of Science
PublisherSpringer Nature
Pages397-416
Number of pages20
DOIs
Publication statusPublished - 2020

Publication series

NameBoston Studies in the Philosophy and History of Science
Volume338
ISSN (Print)0068-0346
ISSN (Electronic)2214-7942

Bibliographical note

Publisher Copyright:
© 2020, Springer Nature Switzerland AG.

All Science Journal Classification (ASJC) codes

  • History and Philosophy of Science
  • Literature and Literary Theory
  • Anthropology
  • Social Sciences (miscellaneous)

Fingerprint

Dive into the research topics of 'Humbug, the Council of Pharmacy and Chemistry, and the Origin of “The Blind Test” of Therapeutic Efficacy'. Together they form a unique fingerprint.

Cite this